HIV Treatment Information Base
News
New guide: HIV testing and sexual transmission
Easy to read summary of sexual risks and questions about testing.
News - latest 
HTB Turkey: April 2012 edition online 15.5.12
New BHIVA guidelines: HIV positive adults and HIV & pregnancy 8.5.12
HIV treatment guides
Take control of your treatment. Easy to read up-to-date guides.
HIV Treatment Bulletin
Technical review of the latest HIV research.
Questions and answers
Treatment questions answered by phone, email or online.
Check your HIV meds
Info and pics for all HIV meds. Links to full patient and prescribing info.
Publications and translations
A-Z list of all our publications.
HTB South
HIV research and news for southern Africa,
Glossary
Medical words and phrases explained
Treatment manual
From CD4 and viral load to understanding clinical trials.
Workshops and training
We run workshops on any aspect of treatment.
ARV4IDUs
Review of HIV drugs for injecting drug users (English & Russian).
UK-Community Advisory Board
The CAB links over 500 advocates and organisations. Free to join.
Русский
Наш сайт уже предоставляет информацию на русском языке.
HTB - recent articles
- Latest reports • Subjects • PDFs
- 18th Annual Conference of the British HIV Association (BHIVA), 18-20 April 2012, Birmingham, UK
- Oral PrEP acceptable to at least 50% of HIV negative gay men
- Recent infections common in UK; 30% gay men aged 15-25 infected within a year of diagnosis
- One third of HIV positive people at five UK clinics have symptomatic depression: link to adherence and viral suppression – 40% cases are untreated
- Hodgkins Lymphoma: survival normalises to HIV negative rates despite more advanced disease at diagnosis
- Promising outcomes from laser ablative treatment of AIN2/3 to prevent anal cancer
- KS in the HAART era includes patients with high CD4 and suppressed viral load: importance of KS chemotherapy for some patients in addtion to ART
HTB South - recent articles
- Latest reports • Subjects • PDFs
- Volume 5 Number 1 January/March 2012
- 2nd International Workshop on HIV & Women, 9-10 January 2012, Bethesda, USA
- Similar efficacy and a few gender related differences in side effects with rilpivirine vs efavirenz at 96-weeks
- The effect of BMI on efficacy, safety and tolerability of lopinavir/r in women
- Hormonal contraception and higher risk of non-AIDS-defining events in Nashville cohort
- Poorer adherence and loss to follow up in Kenyan women who are pregnant when enrolled to ART programmes
- 5th HIV Persistence Workshop on HIV Reservoirs, 6-9 December 2011, West Indies
Q and A - recent questions
- Recent questions and answers • Ask a question • Subjects
- I’m worried about my CD4 and have resistance, neuropathy and arthritis
- What is the life expectancy of an HIV positive child?
- What is the difference between Trustiva and Truvada?
- My 4 year old daughter’s CD4 has dropped, what does this mean?
- Pregnant and newly diagnosed, do I need to take ARVs?
- I am 24 years old and HIV positive and I have lost all self esteem
- How much does treatment cost?
Mini site map
Adapting i-Base materials • Pictures and diagrams • News • Phoneline • Q and A • Order
HIVTRI training partner • HTB • HTB South • ARV4IDUs • Treatment guides • Manual
i-Base on YouTube • About us • Contact • Annual report • Copyright waiver
Contact info
This site complies with the HONcode standard for trustworthy health information. Verify here.
HIV i-Base
4th Floor, 57 Great Suffolk Street, London, SE1 0BB.
Tel + 44 (0) 20 7407 8488. Fax + 44 (0) 20 7407 8489.
Email admin@i-base.org.uk.
Registered charity no: 1081905. Company reg no: 3962064.
HIV i-Base
Treatment phoneline: 0808 800 6013 • Mon-Wed 12-4pm • Office: 020 7407 8488 • Email: admin@i-base.org.uk • Website: www.i-base.info